Adjunctive use of tafluprost with timolol provides additive effects for reduction of intraocular pressure in patients with glaucoma
Egorov E., Ropo A., Erichev V., Astakhov Y., Alekseev V., Takhchidi K., Zhaboedov G., Pasechnikova N., Kaljurand K., Palumaa K., Lagnovska G., Eugeny E.E.A., Staritskaya T.V., Evgen'evna E.T., Borisovna R.T., Sheremetyeva S.S., Oganezova J.G., Petrovich E.V., Vagizona Y.L., Sergueevich A.Y., Alekseevna D.G., Borisovna L.A., Kasimovna A.L., Victorovich P.A., Levko M., Martynova E., Kolotov A., Mironova E.M., Proshina O.I., Kozlova E.E., Sochinskaya V.K., Grishina T.S., Zhaboedov G.D., Petrenko O.V., Tymoshenkova O.V., Vitovska O.P., Kurilina O.I., Parkhomenko O.G., Pasechnokova N.V., Korol A.R., Klyuev G.O., Romodanova K.S., Nevska A., Padanevych E., Kaljurand K., Pastak M., Seljagina N., Palumaa K., Somma K., Laganovska G., Baumane K.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Clinical development
-
Affiliations
Russian State Medical University, 1 Ostrovitjanova Street, 117997 Moscow, Russian Federation; Santen Oy, Clinical Research, Helsinki, Finland